Marta Albalate
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Marta Albalate has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Roberto Alcázar
Servicio de Nefrología, Hospital Universitario Infanta Leonor, Madrid, Spain
3 shared publications Juan Antonio Martín-Navarro
Servicio de Nefrología, Hospital Infanta Leonor, Madrid, España
2 shared publicationsMarta Puerta
Servicio de Nefrología, Hospital Infanta Leonor, Madrid, España
2 shared publications- Mayra Ortega
Instituto Geológico Minero y Metalúrgico (INGEMMET)
2 shared publications - Patricia de Sequera
Nefróloga. Hospital Universitario Infanta Leonor
2 shared publications Carolina Peña‐Martínez
Departamento de Farmacología y Toxicología Facultad de Medicina Universidad Complutense Madrid Spain
1 shared publication
Latest Publications
- 9 February 2021
- Published by Wiley in Artificial Organs
- Vol. 45 (10) , 1183-1188
Effective glutamate clearance from the systemic circulation by hemodialysis: Potential relevance for cerebral ischemia management
High glutamate levels after head trauma or cerebral ischemia have neurotoxic effects. The objective of the present study was to evaluate the efficacy of hemodialysis to remove glutamate from the blood and to assess the behavior of this small molecule. Ten patients with end‐renal disease on hemodialysis were included in the study. Glutamate clearance was evaluated within the first hour of hemodialysis on a midweek dialysis day on five patients who underwent low flux hemodialysis, whereas the other five patients underwent highly efficient hemodialysis (high flux hemodialysis on one day and online hemodiafiltration on another day). Glutamate clearance with hemodialysis was very effective and did not show any differences between the techniques (low flux: 214 [55], high flux: 204 [37], online hemodiafiltration: 202 [16], median (interquartile range), P = .7). Glutamate clearance was almost equivalent to vascular access plasma flow and it was not affected by dialyzer permeability or ultrafiltration rate. After a hemodialysis session, a significant decrease in glutamate blood level was observed (prehemodialysis: 59.7 [36.1], posthemodialysis 37.0 [49.2], P = .005). Dialysis performed under fasting condition showed higher glutamate reduction rate (60%) than that under feeding condition (20%). Hemodialysis may be an effective method to reduce glutamate blood levels, and the molecule clearance does not differ between the different techniques used. Considering previous results in experimental models, hemodialysis without hemodynamic stress, could be considered for reducing glutamate neurotoxic effects in acute ischemic strokes of patients in chronic hemodialysis programs.
- 9 February 2021
- Published by Wiley in Artificial Organs
- Vol. 45 (10) , 1183-1188
Effective glutamate clearance from the systemic circulation by hemodialysis: Potential relevance for cerebral ischemia management
High glutamate levels after head trauma or cerebral ischemia have neurotoxic effects. The objective of the present study was to evaluate the efficacy of hemodialysis to remove glutamate from the blood and to assess the behavior of this small molecule. Ten patients with end‐renal disease on hemodialysis were included in the study. Glutamate clearance was evaluated within the first hour of hemodialysis on a midweek dialysis day on five patients who underwent low flux hemodialysis, whereas the other five patients underwent highly efficient hemodialysis (high flux hemodialysis on one day and online hemodiafiltration on another day). Glutamate clearance with hemodialysis was very effective and did not show any differences between the techniques (low flux: 214 [55], high flux: 204 [37], online hemodiafiltration: 202 [16], median (interquartile range), P = .7). Glutamate clearance was almost equivalent to vascular access plasma flow and it was not affected by dialyzer permeability or ultrafiltration rate. After a hemodialysis session, a significant decrease in glutamate blood level was observed (prehemodialysis: 59.7 [36.1], posthemodialysis 37.0 [49.2], P = .005). Dialysis performed under fasting condition showed higher glutamate reduction rate (60%) than that under feeding condition (20%). Hemodialysis may be an effective method to reduce glutamate blood levels, and the molecule clearance does not differ between the different techniques used. Considering previous results in experimental models, hemodialysis without hemodynamic stress, could be considered for reducing glutamate neurotoxic effects in acute ischemic strokes of patients in chronic hemodialysis programs.
- Open Access
- 23 January 2021
- Published by Elsevier in Nefrología
- Vol. 43 (1) , 158-159
Un curioso caso de fracaso renal agudo en tiempos del COVID-19
- 23 January 2021
- Published by Elsevier in Nefrología
- Vol. 43 (1) , 158-159
Open AccessUn curioso caso de fracaso renal agudo en tiempos del COVID-19
- Open Access
- 1 September 2020
- Published by Elsevier in Nefrología
- Vol. 40 (5) , 552-562
La hipomagnesemia en hemodiálisis se asocia a mayor riesgo de mortalidad: su relación con el líquido de diálisis
- 1 September 2020
- Published by Elsevier in Nefrología
- Vol. 40 (5) , 552-562
Open AccessLa hipomagnesemia en hemodiálisis se asocia a mayor riesgo de mortalidad: su relación con el líquido de diálisis
- 1 April 2010
- Vol. 30 (30) , 143-6
Nuevas fórmulas para estimar el filtrado glomerular. Hacia una mayor precisión en el diagnóstico de la enfermedad renal crónica
- 1 April 2010
- Vol. 30 (30) , 143-6
Nuevas fórmulas para estimar el filtrado glomerular. Hacia una mayor precisión en el diagnóstico de la enfermedad renal crónica